Update Review about Metabolic Myopathies

Area of Science:

• Neurology
• Genetics
• Biochemistry

Background:

• Metabolic myopathies are a diverse group of inherited disorders affecting muscle cell metabolism.
• These conditions manifest with variable symptoms including weakness, muscle wasting, and exercise intolerance.
• Pathophysiology is complex, involving defects in enzymatic pathways crucial for muscle energy production.

Purpose of the Study:

• To review and synthesize recent findings on the etiology and phenotype of metabolic myopathies.
• To highlight new insights into the genetic basis and clinical presentation of these disorders.
• To discuss the current landscape of diagnosis and treatment strategies.

Main Methods:

• Systematic literature review of recent publications.
• Analysis of studies focusing on genetic defects and clinical manifestations.
• Synthesis of information on diagnostic approaches and therapeutic interventions.

Main Results:

• The number of identified metabolic myopathies is increasing, with recent gene discoveries including PGM1, GYG1, and KARS.
• Clinical presentations range from fixed deficits to episodic abnormalities, affecting various muscle groups.
• Current treatment options are primarily symptomatic and supportive.

Conclusions:

• The field of metabolic myopathies is rapidly evolving, driven by next-generation sequencing technologies.
• Expanded genetic knowledge is crucial for a better understanding of pathophysiology and the development of novel therapeutic strategies.
• Further research is needed to establish evidence-based diagnostic and treatment guidelines.